The three major subtypes of breast cancer, based on receptor status, are estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-positive (HER2+), and triple-negative breast cancer (TNBC). Here, ERBB2 is linked to triple-negative breast carcinoma.